Adenosine deaminase (ADA; adenosine aminohydrolase, EC 3.5.4.4) deficiency is one cause of the genetic disease severe combined immunodeficiency. To identify mutations responsible for ADA deficiency, we synthesized cDNAs to ADA mRNAs from two cell lines, GM2756 and GM2825A, derived from ADA-deficient immunodeficient patients. Sequence analysis of GM2756 cDNA clones revealed a different point mutation in each allele that causes amino acid changes of alanine to valine and arginine to histidine. One allele of GM2825A also has a point mutation that causes an alanine to valine substitution. The other allele of GM2825A was found to produce an mRNA in which exon 4 had been spliced out but had no other detrimental mutations. S1 nuclease mapping of GM2825A mRNAs showed equal abundance of the full-length ADA mRNA and the ADA mRNA that was missing exon 4. Several of the ADA cDNA clones extended 5' of the major initiation start site, indicating multiple start sites for ADA transcription. The point mutations in GM2756 and GM2825A and the absence of exon 4 in GM2825A appear to be directly responsible for the ADA deficiency. Comparison of a number of normal and mutant ADA cDNA sequences showed a number of changes in the third base of codons. These changes do not affect the amino acid sequence. Analyses of ADA cDNAs from different cell lines detected aberrant RNA species that either included intron 7 or excluded exon 7. Their presence is a result of aberrant splicing of pre-mRNAs and is not related to mutations that cause ADA deficiency.
Adenosine deaminase (ADA; adenosine aminohydrolase, EC 3.5.4.4) is part of the purine salvage pathway catalyzing the deamination of adenosine and deoxyadenosine. While present in all mammalian tissues, ADA levels are regulated during both differentiation and development, particularly in lymphoid cells (1, 2) . In humans, the genetic deficiency of ADA causes severe combined immunodeficiency, which is characterized by the failure of both B and T lymphocytes to function properly (3, 4) . B-lymphoblast cell lines have been established from a number of ADA-deficient immunodeficient patients. Investigations of these cell lines have indicated that most of the genetic defects underlying ADA deficiency cause structural changes in the ADA protein (5, 6) . Point mutations altering the ADA amino acid sequence have been reported for the ADA-deficient cell lines GM2471 (7) and GM1715 (8) .
Relative levels of ADA mRNA in the ADA-deficient cell lines GM2825A and GM2756 are normal (9) . GM2825A cells contain mRNAs of abnormal size (6) . Both lines contain <5% of normal ADA activity and immunoreactive protein (5) . We describe here sequence analysis of ADA cDNA from these ADA-deficient cell lines. We have identified mutations that we believe account for ADA protein instability in GM2756 and GM2825A. We also report evidence for aberrancies of RNA splicing in both normal and ADA-deficient cells.
METHODS
Poly(A)+ RNA Isolation. All cell lines were obtained from the Human Genetic Mutant Cell Repository (Camden, NJ). Poly(A)+ RNA was isolated from whole cell extracts by guanidium thiocyanate extraction, cesium chloride gradient centrifugation, and oligo(dT) chromatography (10) .
SI Nuclease Mapping. A 1330-base-pair (bp) BamHI/Nco I restriction fragment derived from pADA211 cDNA (6) (Fig.  1 , probe II) was 3'-end-labeled with [a-32P]dCTP (11) . An excess of probe was hybridized to 2 jig of poly(A)+ RNA or with 2 ptg of calf liver tRNA. The hybridization products were digested with SI nuclease (Pharmacia) at 1100 units/ml at room temperature for 1 hr (12) . The digestion products were separated on a 15-cm-long 4.5% polyacrylamide gel containing 8.3 M urea.
Preparation and Analysis of B-Lymphoblast cDNA Libraries. cDNA was synthesized by the method of Gubler and Hoffman (13) . The size-selected cDNA was tailed with terminal deoxynucleotidyltransferase and dCTP, annealed with G-tailed Pst I-cut pBR322, and transformed into competent Escherichia coli RR1. Tetracycline-resistant colonies were transferred to nitrocellulose master filters, which were used to prepare two replicas on Zetabind membranes (AMF Cuno, Meriden, CT). Filters were processed by the procedure of Geyer and Johnson (14) , screened by hybridization with cDNA probes derived from pADA211 (6) by Nco I digestion (Fig. 1, probe I ) or Pst I digestion (Fig. 1, probe III) , and labeled by the random primer method (15) . Pst I fragments of the ADA cDNAs were subcloned into M13mpl8 and sequenced by a modified dideoxy-chain termination method (16) . To resolve compressions, sequencing reactions were carried out with 7-deaza-dGTP (Boehringer Mannheim) (17) .
Blot Hybridization Analysis of Genomic DNA. High molecular weight genomic DNA was isolated (18) and 10,g was cut with various restriction enzymes. Fragments were electrophoresed through a 1.0% agarose gel. The gel was processed by modification (19) of the Southern transfer procedure (20) using GeneScreenPlus (New England Nuclear). Probes were 32P-labeled by the random primer method (15 seen at the top of the autoradiogram in Fig. 2 The bands of 540 and 621 bases in lanes B, C, and D correspond to the sizes anticipated from protection of the probe by ADA RNAs with intron 6 present or exon 7 absent (540 bases) and intron 7 present or exon 8 absent (621 bases). The faintness of the bands relative to the intensity of the bands corresponding to full-length protection of the probe indicates that they are minor species. In other S1 nuclease protection mapping experiments (data not shown) using a probe that was 5'-end-labeled at the junction of exons 8 and 9, minor species were seen that signaled the presence of aberrant mRNAs with either exon 7 absent or intron 7 present. There was no evidence of mRNAs containing intron 6. The 540-and 621-base S1 nuclease-protected products were also seen in mapping experiments with total cellular RNAs isolated from two T-lymphoid lines, MOLT-4 and CCRF-CEM (data not shown). That these ADA mRNA species are found when T-cell RNA is mapped indicates that the splicing aberrations seen in the B-cell RNAs are not specific to B cells and therefore do not represent a posttranscriptional processing pathway specific to B cells.
Sequence Analysis of ADA cDNAs from Deficient Cell Lines GM2756 and GM2825A. We have cloned and sequenced cDNAs corresponding to poly(A)+ RNAs encoded by both ADA alleles for the cell line GM2756 (Fig. 3) . Each allele has a single point mutation affecting the amino acid sequence and several point mutations not affecting the amino acid sequence. Clone 2756-13b extends from one base short of the major transcription initiation site into the poly(A) tail. Compared to the consensus ADA cDNA sequence, clone 2756-13b has a base change at position 1081 (GCG to GTG), which results in an amino acid change of alanine to valine at amino acid 329. Clone 2756-15 is a full-length cDNA for the other ADA allele. In this allele, a point mutation at base 727 (CGT to CAT) results in an arginine to histidine change at amino acid 211. In addition to these point mutations, each allele has a point mutation in the third base of a codon that does not alter the amino acid encoded ( Fig. 3 ; Table 1 , columns a and b). In clone 2756-13b, the codon for Ser-110 is TCT rather than TCC, as found in the consensus sequence. In clone 2756-15, the codon for Val-629 is GTA rather than GTG. Additional clones of each of the alleles were also analyzed. These partial clones have unusual characteristics, which suggest occasional aberrant splicing of ADA pre-mRNA. Clone 2756-la includes intron 7. We have previously reported a similar ADA cDNA sequence pADA3-3 (21) . In both cases, the intron 7 sequence is identical to intron 7 of the normal ADA gene (24, 25 we do not believe that the absence of exon 7 or the inclusion of intron 7 is relevant to ADA deficiency.
We have previously shown by molecular hybridization to an ADA-specific cDNA probe that the ADA-deficient cell line GM2825A has two codominant mature mRNA species, a full-length 1.6-kilobase (kb) message and a shortened 1.45-kb message (6) . The S1 nuclease mapping reported above indicates that the 1.45-kb message has a deletion of exon 4. Sequence analysis of two separate GM2825A cDNA clones (Fig. 4) confirms this observation. Clone 2825A-17b is a partial cDNA with 1148 bases of the total sequence. Exon 4 is cleanly deleted from this clone. This cDNA has no other mutations that alter the ADA amino acid sequence. A second clone, 2825A-20, representing the same ADA allele, is missing exon 7 as well as exon 4. The deletion of exon 7 corresponds to that seen in clone 2756-2. Clone 2825A-10 represents the other ADA allele of this cell line (Fig. 4) . It has only one point mutation that alters an amino acid. This mutation at base 1081 (GCG to GTG) changes amino acid 329 from alanine to valine. While this change is identical to the one seen in clone 2756-13b, these clones do not represent the same ADA allele. Each has another distinct mutation that does not alter the amino acid sequence (Figs. 3 and 4 ; Table  1 , columns a and c). These mutations are in the codon for Ser-110 in clone 2756-13b and for Val-629 in clone 2825A-10.
Clones 2825A-10 and 2825A-20 are also unusual in that they include an additional 48 bases and 31 bases, respectively, 5' to the major transcription initiation site. These additional 5' sequences agree with genomic sequence of this region (24, 25) and indicate that there are multiple transcription initiation sites within the 5' end of the human ADA gene. S1 nuclease analysis of the 5' ends of ADA mRNA in our laboratory (J.C.S., unpublished data) has shown that there is a major initiation site, base 1 of the consensus sequence, and several very minor initiation sites. Multiple initiation sites have been reported for the murine ADA gene (26) .
Genomic DNA Analysis. Deletions such as absence of exons 4 and 7 in ADA mRNAs might be due to small deletions in the gene. Consequently, genomic DNA from GM2756, GM-2825A, and the normal cell line GM2184 was analyzed by blot hybridization. DNA was digested with Nco I or HindIII, blotted, and hybridized with cDNA probe III (Fig. 1) , Sma I/Bgl II genomic probe (Fig. 5A) or HindIII genomic probe (Fig. SB) . A partial or complete deletion of exon 7 or the flanking introns would affect the size or intensity of the 1123-bp Nco I fragment (Fig. SA) . Nco I fragments of identical size and intensity were detected in all three cell lines with both the cDNA probe III and the Sma I/Bgl II genomic probe (Fig. SC) . Therefore, we conclude that there are no Lys/Lys
Arg/His
Base changes compared to the consensus ADA cDNA sequence, as described in Fig. 3 , are bold face. The paired amino acids are derived from the codon sequence of the consensus and the codon sequence with the noted base change. Base number 1 is the first base of the major initiation start site (24 large deletions affecting intron 6, exon 7, and intron 7 in the ADA-deficient cell lines GM2756 and GM2825A. The same general strategy was used to analyze the exon 4 deletion in GM2825A. GM2825A DNA was digested with HindIII, blotted, and hybridized with a genomic 1185-bp HindIII probe (Fig. 5B) . If there were a deletion of exon 4 within one ADA allele, blot hybridization would give a 1185-bp band representing a normal-sized allele and a smaller band representing the allele with a portion of exon 4 and/or introns 3 and 4 missing. HindIII fragments of equal size and intensity were detected in GM2825A and the normal cell line GM2184, A deletion of the entire 1185-bp HindIII fragment would not be detected by the HindIII probe. However, such a deletion would affect the size and intensity of the 587-bp Nco I fragment detected by probe III (Fig. 5A) . The normal size and intensity of this band in GM2825A excludes the possibility of a large deletion involving exon 4 in the gene.
DISCUSSION
We have described the construction and analysis of cDNA libraries from the ADA-deficient cell lines GM2756 and GM2825A. GM2825A has a defect in one allele that leads to an abnormal RNA species found to be missing exon 4 (27) indicates that the region from amino acid 208 to 213 becomes decidedly more hydrophilic when amino acid 211 is changed from arginine to histidine. The alanine to valine substitution has virtually no effect on the predicted hydropathicity profile or on the predicted secondary structure of the protein as determined by the method of Garnier et al. (28) . Because Sharp (29) , which is (A/C)AG: GT(A/G)AGT. The three bases within the exon preceding the splice site and the 4 bases following the GT (invariant bases +1 and +2) are only moderately conserved (30) . The exon 7/intron 7 splice site of ADA has alternate bases at positions -3 and +6. Aebi et al. (31) have shown that changing the base at position -3 from adenine or cytosine to guanine and the base at +6 from thymine to adenine or guanine of the 5' splice site of intron 2 impairs correct splicing and promotes joining of exon 1 to exon 3 in the large rabbit f3-globin RNA. Similar inefficient use of the 5' splice site of intron 7 in ADA where base -3 is guanine and base +6 is guanine may account for the two aberrant exon 7 intron 7 mRNA species. In one case, the inefficient utilization of the intron 7 splice site leads to mRNA species without exon 7. In the second case, the splicing process fails to remove intron 7. The efficiency of splicing may also be influenced by RNA secondary structures (32) and the size of intron 7. Intron 7 in ADA contains only 76 bases and is near the minimum intron size of 60 bases required for accurate splicing (30) . This work was supported by National Institutes of Health Research Grant HD19919.
